A Utah-based biotech company that had refused to let four patients access their full genetic information has reversed course, a day before the American Civil Liberties Union filed a complaint with the federal government on behalf of patients in general. Myriad Genetics provided the patients late Wednesday with genetic information they requested in February. The ACLU filed a complaint on Thursday with the U.S. Department of Health and Human Services, calling on Myriad to release complete gene information to all patients whenever requested.
Friday, May 20, 2016
Biotech Company and Patients Face Off to Gain Access to Their Genetic Tests
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment